1)国立がん研究センターがん情報サービス:最新がん統計 http://ganjoho.jp/reg_stat/statistics/stat/summary.html(2017年5月閲覧)
2)Welch HG, Albertsen PC:Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening:1986-2005. J Natl Cancer Inst 101:1325-1329, 2009
3)Bibbins-Domingo K, et al:The US Preventive Services Task Force 2017 Draft Recommendation Statement on Screening for Prostate Cancer;An invitation to review and comment. JAMA 317:1949-1950, 2017
4)日本泌尿器科学会(編):前立腺癌診療ガイドライン,2016年版,メディカルレビュー社,2016
5)Abdollah F, et al:Trans-rectal versus trans-perineal saturation rebiopsy of the prostate;Is there a difference in cancer detection rate? Urology 77:921-925, 2011
6)Raaijmakers R, et al:Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology 60:826-830, 2002
7)Epstein JI, et al:A contemporary prostate cancer grading System;A validated alternative to the Gleason Score. European Urology 69:428-435, 2016
8)Brierley JD, et al(eds):UICC TNM Classification of Malignant Tumours, 8th ed, Wiley Blackwell, 2017
9)日本泌尿器科学会(編):前立腺癌取り扱い規約,第4版,2010
10)NCCNガイドライン─前立腺がん,第3版,2016 http://www.tri-kobe.org/nccn/guideline/urological/japanese/prostate.pdf(2017年5月閲覧)
11)D'Amico AV, et al:Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280:969-974, 1998
12)Parker C, et al:Cancer of the prostate;ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 26:69-77, 2015
13)Bill-Axelson A, et al:Radical prostatectomy or watchful waiting in early prostate cancer. N Engl J Med 370:932-942, 2014